Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 7/20 | 0.48 |
| ▸ | CA1 | P00915 | 7/20 | 0.48 |
| ▸ | CA2 | P00918 | 7/20 | 0.48 |
| ▸ | CA9 | Q16790 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4893583 | 0.90 | CA12 (0.56) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL18844759 | 0.88 | IDO1 (0.42) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL18354659 | 0.86 | TDP1 (0.51) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL12284963 | 0.82 | CA12 (0.49) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL30206955 | 0.82 | TDP1 (0.55) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL10447857 | 0.81 | TDP1 (0.47) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL18360380 | 0.81 | TDP1 (0.47) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL26785163 | 0.81 | IDO1 (0.44) | IDO1TDP1CA12CA1CA2 | |
| SCHEMBL15965828 | 0.80 | MTNR1A (0.43) | GAAALDH1A1 | |
| SCHEMBL2279724 | 0.80 | TDP1 (0.53) | IDO1TDP1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240141084-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SILQ TECHNOLOGIES CORPORATION | 2024-05-02 | — | — | US | disclosed |
| US-11807701-B2 | Biofouling resistant coatings and methods of making and using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230233743-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SILQ TECHNOLOGIES CORPORATION | 2023-07-27 | — | — | US | disclosed |
| US-11541153-B2 | Biofouling resistant coatings and methods of making and using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-03 | — | — | US | disclosed |
| WO-2022255479-A1 | MEDIUM-SIZED MOLECULE COMPOUND CONJUGATED BODY FOR IMPROVING BLOOD KINETICS OF MEDIUM-SIZED MOLECULE COMPOUND AND METHOD FOR PRODUCING SAME | タグシクス・バイオ株式会社 | 2022-12-08 | — | — | WO | disclosed |
| US-20200385506-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SILQ TECHNOLOGIES CORPORATION | 2020-12-10 | — | — | US | disclosed |
| WO-2020247629-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-12-10 | — | — | WO | disclosed |
| CN-112004844-A | Biofouling resistant coatings and methods of making and using the same | 加州大学评议会 | 2020-11-27 | — | — | CN | disclosed |
| US-20200338240-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SILQ TECHNOLOGIES CORPORATION | 2020-10-29 | — | — | US | disclosed |
| EP-3717531-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | The Regents of the University of California (US) | 2020-10-07 | — | — | EP | disclosed |
| WO-2016181304-A1 | COPOLYMER COMPOSITIONS AND USES THEREOF | ETH Zürich (CH) | 2016-11-17 | — | — | WO | disclosed |
| EP-3093027-A1 | COPOLYMER COMPOSITIONS AND USES THEREOF | ETH Zurich (CH) | 2016-11-16 | — | — | EP | disclosed |
| EP-3093027-A1 | COPOLYMER COMPOSITIONS AND USES THEREOF | ETH Zurich (CH) | 2016-11-16 | — | — | EP | disclosed |
| US-20140221577-A1 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2014-08-07 | — | — | US | disclosed |
| US-8617592-B2 | Self-assembled particles from zwitterionic polymers and related methods | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2013-12-31 | — | — | US | disclosed |
| US-20120259021-A1 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2012-10-11 | — | — | US | disclosed |
| EP-2496614-A2 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | University Of Washington Through Its Center For Commercialization (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011057225-A2 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CARESTREAM HEALTH, INC. | 2008-04-24 | — | — | US | disclosed |
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CARESTREAM HEALTH, INC. | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200338240-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SLC11A2, FHIT, MB | IDO1 4205/4885TDP1 1271/4885CA12 525/4885 |
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CD47, MSN, CLTA | IDO1 1578/4885TDP1 4100/4885CA12 170/4885 |
| US-11541153-B2 | Biofouling resistant coatings and methods of making and using the same | SLC11A2, FHIT, MB | IDO1 4205/4885TDP1 1271/4885CA12 525/4885 |
| US-20120259021-A1 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | ZW10, PHOSPHO1, CLTA | IDO1 4111/4885TDP1 3181/4885CA12 34/4885 |
| US-20230233743-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | SLC11A2, FHIT, MB | IDO1 4205/4885TDP1 1271/4885CA12 525/4885 |
| US-20140221577-A1 | SELF-ASSEMBLED PARTICLES FROM ZWITTERIONIC POLYMERS AND RELATED METHODS | ZW10, PHOSPHO1, CLTA | IDO1 4111/4885TDP1 3181/4885CA12 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.